Pan-TEAD Inhibitor

Advertisement

cGxPJobs Banner

Insilico Medicine Presents ISM6331 Phase 1 Data at ESMO

Cambridge, MA, July 27, 2026 Insilico Medicine has announced that first-in-human Phase 1 clinical trial data for ISM6331, its...

By cGxPwire Editor
July 29, 2026

Read More

Advertisement

cGxPJobs

Directory